EUROPEAN FEDERATION OF MEDICINAL CHEMISTRY-22ND INTERNATIONAL SYMPOSIUM ON MEDICINAL CHEMISTRY (EFMC-ISMC 2012) BERLIN, GERMANY - SEPTEMBER 2-6, 2012

被引：1

作者：

Castaner, R. ^{[1
]}

机构：

[1] Thomson Reuters, Barcelona, Spain

来源：

DRUGS OF THE FUTURE | 2012年 / 37卷 / 11期

关键词：

Antimalarials; Tuberculosis; mTOR inhibitors; PI3K inhibitors; Anxiety and mood disorders; Antithrombotics;

D O I：

10.1358/dof.2012.037.011.1900472

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The 22(nd) edition of the biennial International Symposium on Medicinal Chemistry (ISMC), sponsored by the European Federation of Medicinal Chemistry (EFMC), was held this year in Berlin. It was jointly organized by the Division of Medicinal Chemistry of the German Chemical Society (GDCh) and the Section of Pharmaceutical/Medicinal Chemistry of the German Pharmaceutical Society (DPhG). The symposium attracted a large international attendance of medicinal and synthetic chemists, as well as experts on drug R&D. This report summarizes some of the progress in the search for cures for malaria and tuberculosis infections.

引用

页码：813 / 816

页数：4